PT98357A - Baculovirus modificado,processo para a sua preparacao e vectores de expressao obtidos a partir do dito baculovirus - Google Patents
Baculovirus modificado,processo para a sua preparacao e vectores de expressao obtidos a partir do dito baculovirusInfo
- Publication number
- PT98357A PT98357A PT98357A PT9835791A PT98357A PT 98357 A PT98357 A PT 98357A PT 98357 A PT98357 A PT 98357A PT 9835791 A PT9835791 A PT 9835791A PT 98357 A PT98357 A PT 98357A
- Authority
- PT
- Portugal
- Prior art keywords
- baculovirus
- pct
- modified
- preparation
- expression vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR909009143A FR2664905B1 (fr) | 1990-07-18 | 1990-07-18 | Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus. |
Publications (2)
Publication Number | Publication Date |
---|---|
PT98357A true PT98357A (pt) | 1992-05-29 |
PT98357B PT98357B (pt) | 1999-01-29 |
Family
ID=9398840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98357A PT98357B (pt) | 1990-07-18 | 1991-07-17 | Baculovirus modificado,processo para a sua preparacao e vectores de expressao obtidos a partir do dito baculovirus |
Country Status (14)
Country | Link |
---|---|
US (1) | US5571709A (pt) |
EP (1) | EP0651815B1 (pt) |
JP (1) | JP3076833B2 (pt) |
AT (1) | ATE151462T1 (pt) |
AU (1) | AU660419B2 (pt) |
CA (1) | CA2087270C (pt) |
DE (1) | DE69125632T2 (pt) |
FR (1) | FR2664905B1 (pt) |
HU (1) | HUT62937A (pt) |
IE (1) | IE912525A1 (pt) |
NO (1) | NO930145L (pt) |
NZ (1) | NZ239032A (pt) |
PT (1) | PT98357B (pt) |
WO (1) | WO1992001801A1 (pt) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT400382B (de) * | 1994-06-24 | 1995-12-27 | Inject Star Poekelmasch | Vorrichtung zum quetschen und auflockern von fleisch |
FR2732035B1 (fr) * | 1995-03-23 | 1997-05-30 | Agronomique Inst Nat Rech | Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede |
JP2003040297A (ja) * | 2001-08-06 | 2003-02-13 | Toppan Printing Co Ltd | オーバーキャップ付封緘キャップ |
ES2516041T3 (es) | 2001-10-10 | 2014-10-30 | Ratiopharm Gmbh | Remodelación y glicoconjugación de la hormona del crecimiento humano (hGH) |
EP2305311A3 (en) | 2001-10-10 | 2011-07-20 | BioGeneriX AG | Glycoconjugation of peptides |
EP1615945B1 (en) | 2003-04-09 | 2011-09-28 | BioGeneriX AG | Glycopegylation methods and proteins/peptides produced by the methods |
JP4889505B2 (ja) | 2004-02-02 | 2012-03-07 | アンブレツクス・インコーポレイテツド | 被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用 |
JP2008503217A (ja) | 2004-06-18 | 2008-02-07 | アンブレツクス・インコーポレイテツド | 新規抗原結合ポリペプチド及びそれらの使用 |
CA2569381A1 (en) | 2004-07-21 | 2006-08-31 | Ambrx, Inc. | Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
WO2009100255A2 (en) | 2008-02-08 | 2009-08-13 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
KR20070090023A (ko) | 2004-12-22 | 2007-09-04 | 암브룩스, 인코포레이티드 | 변형 인간 성장 호르몬 |
JP2008525032A (ja) | 2004-12-22 | 2008-07-17 | アンブレツクス・インコーポレイテツド | 組換えヒト成長ホルモンを発現及び精製するための方法 |
WO2006068802A2 (en) | 2004-12-22 | 2006-06-29 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
KR101224781B1 (ko) | 2004-12-22 | 2013-01-21 | 암브룩스, 인코포레이티드 | 비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물 |
WO2006069246A2 (en) | 2004-12-22 | 2006-06-29 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
CA2609205A1 (en) * | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Improved human interferon molecules and their uses |
AU2005335491B2 (en) * | 2005-08-18 | 2010-11-25 | Ambrx, Inc. | Compositions of tRNA and uses thereof |
ATE500215T1 (de) * | 2005-11-08 | 2011-03-15 | Ambrx Inc | Beschleuniger für die modifikation nichtnatürlicher aminosäuren und nichtnatürlicher aminosäurepolypeptide |
ES2547554T3 (es) * | 2005-11-16 | 2015-10-07 | Ambrx, Inc. | Métodos y composiciones que comprenden aminoácidos no naturales |
KR101423898B1 (ko) * | 2005-12-14 | 2014-07-28 | 암브룩스, 인코포레이티드 | 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도 |
CN101541955B (zh) | 2006-09-08 | 2016-09-28 | Ambrx公司 | 用于脊椎动物细胞的杂合抑制tRNA |
EP2069396B1 (en) | 2006-09-08 | 2015-10-21 | Ambrx, Inc. | Modified human plasma polypeptide or fc scaffolds and their uses |
PT2064333E (pt) | 2006-09-08 | 2014-06-09 | Ambrx Inc | Supressor híbrido arnt para células de vertebrados |
PL2068909T3 (pl) | 2007-03-30 | 2012-09-28 | Ambrx Inc | Modyfikowane polipeptydy fgf-21 i ich zastosowanie |
EP2076533B1 (en) | 2007-05-02 | 2014-10-08 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
ES2632504T3 (es) | 2007-11-20 | 2017-09-13 | Ambrx, Inc. | Polipéptidos de insulina modificados y sus usos |
JP5680534B2 (ja) | 2008-07-23 | 2015-03-04 | イーライ リリー アンド カンパニー | 修飾されているウシg−csfポリペプチドおよびそれらの使用 |
PE20110832A1 (es) | 2008-09-26 | 2011-11-24 | Ambrx Inc | Polipeptidos de eritropoyetina felina modificados |
MX348657B (es) | 2008-09-26 | 2017-06-21 | Ambrx Inc | Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales. |
WO2010117786A1 (en) * | 2009-03-30 | 2010-10-14 | Mount Sinai School Of Medicine Of New York University | Influenza virus vaccines and uses thereof |
AU2010254136B2 (en) | 2009-05-26 | 2016-09-29 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
WO2010144794A1 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
EA201290541A1 (ru) | 2009-12-21 | 2013-05-30 | Амбркс, Инк. | Модифицированные бычьи соматотропиновые полипептиды и их применение |
CN102666578A (zh) | 2009-12-21 | 2012-09-12 | Ambrx公司 | 经过修饰的猪促生长素多肽和其用途 |
EP2536425B1 (en) | 2010-02-18 | 2019-06-19 | Icahn School of Medicine at Mount Sinai | Vaccines for use in the prophylaxis and treatment of influenza virus disease |
AU2011235220B2 (en) | 2010-03-30 | 2016-03-10 | Mount Sinai School Of Medicine | Influenza virus vaccines and uses thereof |
WO2011156594A2 (en) | 2010-06-09 | 2011-12-15 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
CA2808596C (en) | 2010-08-17 | 2020-12-15 | Ambrx, Inc. | Modified relaxin polypeptides and their uses |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
AR083006A1 (es) | 2010-09-23 | 2013-01-23 | Lilly Co Eli | Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas |
RU2632651C2 (ru) | 2011-05-11 | 2017-10-06 | Чилдрен'С Медикал Сентер Корпорейшн | Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение |
IN2014CN00688A (pt) * | 2011-07-27 | 2015-04-03 | Genethon | |
US10131695B2 (en) | 2011-09-20 | 2018-11-20 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccines and uses thereof |
JP2016508133A (ja) | 2012-12-18 | 2016-03-17 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルスワクチン及びその使用 |
EP3511417B1 (en) | 2013-01-28 | 2023-05-31 | Kansas State University Research Foundation | Rift valley fever virus glycoproteins, gn and gc, and their use |
WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
JP6702962B2 (ja) | 2014-10-24 | 2020-06-03 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 改変fgf−21ポリペプチドおよびその使用 |
JP2018504412A (ja) | 2015-01-23 | 2018-02-15 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルスワクチン接種レジメン |
CA3023143A1 (en) | 2016-06-15 | 2017-12-21 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
CN110637027A (zh) | 2017-02-08 | 2019-12-31 | 百时美施贵宝公司 | 包含药代动力学增强子的修饰的松弛素多肽及其用途 |
WO2018187706A2 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
AT519931A1 (de) * | 2017-05-12 | 2018-11-15 | Kepler Univ Gmbh | Herstellung von armierter DNA |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE78293T1 (de) * | 1983-05-27 | 1992-08-15 | Texas A & M Univ Sys | Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors. |
-
1990
- 1990-07-18 FR FR909009143A patent/FR2664905B1/fr not_active Expired - Fee Related
-
1991
- 1991-07-17 HU HU93118A patent/HUT62937A/hu unknown
- 1991-07-17 EP EP91913605A patent/EP0651815B1/fr not_active Expired - Lifetime
- 1991-07-17 JP JP03512351A patent/JP3076833B2/ja not_active Expired - Fee Related
- 1991-07-17 WO PCT/FR1991/000588 patent/WO1992001801A1/fr active IP Right Grant
- 1991-07-17 PT PT98357A patent/PT98357B/pt not_active IP Right Cessation
- 1991-07-17 CA CA002087270A patent/CA2087270C/fr not_active Expired - Fee Related
- 1991-07-17 DE DE69125632T patent/DE69125632T2/de not_active Expired - Fee Related
- 1991-07-17 AU AU82324/91A patent/AU660419B2/en not_active Ceased
- 1991-07-17 US US07/966,197 patent/US5571709A/en not_active Expired - Fee Related
- 1991-07-17 AT AT91913605T patent/ATE151462T1/de not_active IP Right Cessation
- 1991-07-18 IE IE252591A patent/IE912525A1/en unknown
- 1991-07-18 NZ NZ239032A patent/NZ239032A/xx unknown
-
1993
- 1993-01-15 NO NO93930145A patent/NO930145L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU8232491A (en) | 1992-02-18 |
NO930145D0 (no) | 1993-01-15 |
EP0651815A1 (fr) | 1995-05-10 |
PT98357B (pt) | 1999-01-29 |
HU9300118D0 (en) | 1993-04-28 |
DE69125632T2 (de) | 1997-10-23 |
WO1992001801A1 (fr) | 1992-02-06 |
FR2664905B1 (fr) | 1994-08-12 |
JPH06500010A (ja) | 1994-01-06 |
CA2087270A1 (fr) | 1992-01-19 |
JP3076833B2 (ja) | 2000-08-14 |
NZ239032A (en) | 1993-10-26 |
ATE151462T1 (de) | 1997-04-15 |
HUT62937A (en) | 1993-06-28 |
EP0651815B1 (fr) | 1997-04-09 |
CA2087270C (fr) | 2001-12-04 |
DE69125632D1 (de) | 1997-05-15 |
FR2664905A1 (fr) | 1992-01-24 |
IE912525A1 (en) | 1992-01-29 |
US5571709A (en) | 1996-11-05 |
NO930145L (no) | 1993-03-15 |
AU660419B2 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT98357A (pt) | Baculovirus modificado,processo para a sua preparacao e vectores de expressao obtidos a partir do dito baculovirus | |
ATE275343T1 (de) | Verarbeitung von pflantzlichem material mit xylanase | |
FI950409A (fi) | Yhdistelmä soluja, DNA-rakenteita, vektoreita ja menetelmiä fytaattia hajoittavien entsyymien ilmentämiseksi toivotuissa suhteissa | |
DE59407237D1 (de) | Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems | |
PT98710A (pt) | Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem | |
ATE229013T1 (de) | Verfahren zur herstellung von hydroxysubstituierten gamma-butyrolactonen | |
PT97602A (pt) | Processo para a preparacao de indolonas neuroprotectoras e de derivados relacionados com as mesmas | |
DE69408099T2 (de) | 5-Methyluridin-Verfahren zur Herstellung von 2',3'-didehydro-3'-desoxythymidin (d4T) im Grossmassstab | |
DE50112186D1 (de) | Expression von Alkalischer Phosphatase in Hefe | |
PT851926E (pt) | Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada | |
ATE308619T1 (de) | Steigerung der genexpression | |
FR2717187B1 (fr) | Usage combiné de deux cassettes d'expression pour la production d'une protéine d'intérêt. | |
EA199901059A1 (ru) | Способ получения энантиомерно обогащенных n-производных лактамов | |
ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
DE69613685T2 (de) | D-aminosäure-oxidase kodierendes dns-fragment | |
PT80985B (pt) | Processo para a preparacao de hidantoinas assimetricas | |
YU46247B (sh) | Postupak za dobijanje 2,2',4,4',6,6'-heksanitrostilbena specifične čistoće i nasipne mase | |
ES2075685T3 (es) | Sintesis de intermediarios en la preparacion de inhibidores de acat. | |
ATE328088T1 (de) | Transketolase-verwandtes protein | |
EP0342422A3 (en) | Process for the preparation of 2',3'-dideoxynucleosides, and intermediates used therein | |
ES2141384T3 (es) | Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina. | |
SE9303822D0 (sv) | Method for purification | |
Norrie | Reproduction of the rosy boa, Lichanura trivirgata. | |
EP0310969A3 (en) | Pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues | |
KR970074931A (ko) | 사람의 태아 간세포에서 분리한 아데닐레이트 키나제 2a 유전자와 그의 염기 서열 및 이의 발현 벡터 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920117 |
|
FG3A | Patent granted, date of granting |
Effective date: 19981009 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20000430 |